This suggests that the resistance of GBM to apoptosis is most likely conferred by over-expression of VDAC1-interacting anti-apoptotic proteins, such as HK and Bcl-2 (Figure 1C) [9, 25]. The gene discussed is BCL2; the disease is glioblastoma.